SCHEMBL198012

SCHEMBL198012

COc1ccc2cc(-c3cc4c(cc3C(=O)c3ccc(-c5ccccc5)cc3)OCO4)[n+](C)cc2c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 8/20 0.49
ACHE P22303 8/20 0.49
EP300 Q09472 7/20 0.49
ALDH1A1 P00352 4/20 0.49
MAPT P10636 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
CYP3A4 P08684 3/20 0.49
CYP2D6 P10635 3/20 0.49
TSHR P16473 3/20 0.49
LMNA P02545 3/20 0.49
KMT2A Q03164 3/20 0.49
CHRM1 P11229 2/20 0.49
DRD2 P14416 2/20 0.49
ADRA2B P18089 2/20 0.49
ADRA2C P18825 2/20 0.49
RXRA P19793 2/20 0.49
DRD1 P21728 2/20 0.49
HTR2B P41595 2/20 0.49
HTT P42858 2/20 0.49
RAD52 P43351 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL128827 0.90 CYP1B1 (0.40) BCHEACHEEP300ALDH1A1MAPT
SCHEMBL16189647 0.85 BCHE (0.52) BCHEACHEEP300ALDH1A1MAPT
SCHEMBL16189646 0.78 BCHE (0.48) BCHEACHEEP300ALDH1A1MAPT
SCHEMBL129768 0.76 PTGS1 (0.44) BCHEACHEEP300ALDH1A1MAPT
Berberine SCHEMBL8028667 0.71 BCHE (0.78) BCHEACHEEP300ALDH1A1MAPT
SCHEMBL13284305 0.70 ALDH1A1 (0.66) BCHEACHEEP300ALDH1A1MAPT
SCHEMBL127656 0.70 ACHE (0.38) BCHEACHEEP300ALDH1A1MAPT
Chelerythrine SCHEMBL9651334 0.70 ALDH1A1 (0.76) BCHEACHEEP300ALDH1A1MAPT
SCHEMBL129791 0.70 ACHE (0.41) BCHEACHEEP300ALDH1A1MAPT
SCHEMBL13283969 0.69 ALDH1A1 (0.64) BCHEACHEEP300ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9227966-B2 Antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-01-05 US disclosed
US-20140315939-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-10-23 US disclosed
US-20120059026-A1 ANTIMICROBIAL AGENTS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059026-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L BCHE 2274/4885ACHE 3213/4885EP300 1918/4885
US-20140315939-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L BCHE 2271/4885ACHE 3734/4885EP300 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.